Methallylescaline HCL CAS: 207740-41-8

CAS NO: 207740-41-8
Methallylescaline HCL
Chemical Name: Methallylescaline HCL
Molecular Formula: C14H21NO3
Formula Weight: 251.32
CAS No.: 207740-41-8
Description Review
Description

Methallylescaline HCL is a synthetic psychedelic compound with structural similarities to mescaline. This compound is a derivative of escaline and was first synthesized in 2011 by Alexander Shulgin, a psychopharmacologist who was known for his work in the field of entheogenic drugs.

Chemical Name:

The chemical name for Methallylescaline HCL is N-(2-(3,5-dimethoxy-4-(2-methylprop-2-en-1-yl)phenyl)ethyl)propan-2-amine hydrochloride.

Molecular Formula:

The molecular formula for Methallylescaline HCL is C17H26ClNO2.

Formula Weight:

The formula weight of Methallylescaline HCL is 313.85 g/mol.

CAS No:

The CAS number for Methallylescaline HCL is 207740-41-8.

Top Ten Keywords from Google and Synonyms:

  1. Psychedelic compound - Methallylescaline HCL is a compound that can cause altered perception and consciousness.
  2. Synthetic - Methallylescaline HCL is a compound that is not found naturally and is produced in laboratories.
  3. Alexander Shulgin - The psychopharmacologist who first synthesized Methallylescaline HCL.
  4. Mescaline - Methallylescaline HCL has structural similarities to this naturally-occurring psychedelic compound.
  5. Escaline - Methallylescaline HCL is a derivative of this synthetic psychedelic compound.
  6. Research chemical - A term used to describe compounds like Methallylescaline HCL that have not been approved for human use.
  7. Entheogen - A substance that is used for spiritual or religious purposes.
  8. Molecular formula - The chemical formula of Methallylescaline HCL.
  9. CAS 207740-41-8 - A unique identifier for Methallylescaline HCL.
  10. Hydrochloride - The salt form of Methallylescaline used for stability and solubility.

Health Benefits of Methallylescaline HCL:

At present, there are no established and approved health benefits of consuming Methallylescaline HCL. It is classified as a research chemical and is not intended for human consumption.

Potential Effects:

The effects of Methallylescaline HCL are not well-known since it has not been extensively studied in humans. It is believed to have psychedelic properties comparable to mescaline, which is known to cause perceptual changes, religious or spiritual experiences, and intense emotional states. Additionally, it may cause cognitive effects, including extreme focus and introspection, and induce a sense of well-being and euphoria. Since Methallylescaline HCL is an empirical compound, it is believed to have distinct effects depending on the individual and dose administered.

Product Mechanism:

Methallylescaline HCL is believed to act by interacting with serotonin receptors in the brain. It can bind to 5-HT2A receptors, which can lead to the perception-altering effects of this compound.

Safety:

Methallylescaline HCL is not approved for human use and has not undergone rigorous safety testing. However, based on its structural similarity to other psychedelic compounds, it is believed to carry similar risks, especially regarding adverse psychological effects. Since reportage regarding the compound continues to be sparse, the understanding regarding its safety and potential risks is incomplete.

Side Effects:

The side effects of Methallylescaline HCL are uncertain at the moment. Psychedelic substances can cause psychological and physical side effects, including hallucinations, anxiety, paranoia, and physical discomforts such as nausea or vomiting. High doses of these substances can raise blood pressure and heart rate, leading to a potentially harmful cardiovascular effect. Overall, Methallylescaline HCL and compounds of this nature have not been shown to be safe enough for human consumption.

Dosing Information:

Since Methallylescaline HCL is not approved for human consumption, dosing information cannot be provided. As a research chemical, it is used primarily in laboratory settings to understand its properties further.

Conclusion:

Methallylescaline HCL is a synthetic psychedelic compound that has not been approved for human consumption. Even though it has similarities to mescaline, relatively little is known about its effects in humans. It is classified as a research chemical, and therefore, researchers should exercise the utmost care while conducting research with this substance. As with all similar substances, Methallylescaline HCL should be used with caution, with proper safety protocols in place, and only when administered correctly in laboratory settings.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code